BioSyent Inc.
RX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.40% | 26.65% | 12.55% | 33.36% | 3.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.40% | 26.65% | 12.55% | 33.36% | 3.33% |
| Cost of Revenue | 36.12% | 41.39% | 19.65% | 56.10% | 1.68% |
| Gross Profit | 4.50% | 22.58% | 10.67% | 27.48% | 3.72% |
| SG&A Expenses | 11.08% | 21.59% | 3.14% | 23.88% | -11.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.54% | 27.59% | 7.55% | 32.95% | -8.33% |
| Operating Income | -8.26% | 24.30% | 30.80% | 34.47% | 54.78% |
| Income Before Tax | 10.56% | 21.47% | 26.30% | 23.22% | 17.95% |
| Income Tax Expenses | -23.40% | 43.54% | 26.30% | 23.21% | 53.45% |
| Earnings from Continuing Operations | 23.98% | 15.09% | 26.31% | 23.22% | 8.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.98% | 15.09% | 26.31% | 23.22% | 8.06% |
| EBIT | -8.26% | 24.30% | 30.80% | 34.47% | 54.78% |
| EBITDA | -3.03% | 26.88% | 28.71% | 34.83% | 50.90% |
| EPS Basic | 26.65% | 18.42% | 30.12% | 27.47% | 10.84% |
| Normalized Basic EPS | -5.19% | 24.98% | 30.11% | 27.62% | 44.18% |
| EPS Diluted | 25.99% | 18.32% | 29.93% | 26.79% | 10.92% |
| Normalized Diluted EPS | -5.58% | 24.89% | 29.53% | 27.02% | 43.94% |
| Average Basic Shares Outstanding | -2.04% | -2.82% | -2.93% | -3.40% | -2.58% |
| Average Diluted Shares Outstanding | -1.75% | -2.67% | -2.51% | -2.99% | -2.46% |
| Dividend Per Share | 11.84% | 10.00% | 9.73% | 4.19% | 9.18% |
| Payout Ratio | -0.11% | -0.07% | -0.15% | -0.18% | -0.02% |